HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Mordenti Selected Research

CRA 2059

3/2002Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Mordenti Research Topics

Disease

1Prostatic Neoplasms (Prostate Cancer)
06/2017
1Ulcerative Colitis
03/2002

Drug/Important Bio-Agent (IBA)

1Androgen Receptors (Androgen Receptor)IBA
06/2017
1enzalutamideIBA
06/2017
1CRA 2059IBA
03/2002
1Tryptases (Tryptase)IBA
03/2002

Therapy/Procedure

1Castration
06/2017